A new study shows the Pfizer-BioNTech vaccine remains 90% effective at preventing COVID-19 hospitalizations for up to six months after being fully vaccinated, even with the more transmissible delta ...
Separately, per the Pfizer-issued report, interim analyses of an ongoing second study in standard-risk adults (EPIC-SR) showed a 70% reduction in hospitalization and no deaths in the treated ...
WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drug-maker joins the race to bring the first ...
Our team at the Advanced Photon Source have helped Pfizer create a COVID-19 treatment. The new drug candidate, Paxlovid, significantly reduced hospitalization and death in adult patients, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results